SEC Form 4 · accession 0001209191-18-054878
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Simard
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jul 27, 2018
Accepted (ET)
Oct 12, 2018 · 3:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $4.26 | Jul 27, 2018 | A | 15,000 | A | May 29, 2019 | May 28, 2028 | Common Stock | 15,000 | 15,000 | I |
Remarks
On July 27, 2018 an employee of XBiotech became the spouse of the reporting person. On May 29, 2018 (the Grant Date) the employee received routine incentive stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of XBiotech Inc. common Stock as quoted by the Nasdaq Stock Market on the Grant Date. The Options vest in four equal annual installments commencing on the first anniversary of the Grant Date with an expiry of ten years from the Grant Date.